Ligand Pharmaceuticals LGND Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's common stock, par value (in dollars per share)?
- Ligand Pharmaceuticals (LGND) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Ligand Pharmaceuticals's common stock, par value (in dollars per share) changed year-over-year?
- Ligand Pharmaceuticals's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Ligand Pharmaceuticals's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.